RFXANK and ovarian carcinoma: Given the up-regulated RFXANK and down-regulated CDC42EP3 and BAMBI in two independent ovarian cancer datasets from Oncomine (Figs. 1A–1B), we expected CDC42EP3 as a potential prognostic target that needs further investigation.